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H I G H L I G H T S
 Skin wound area expansion and weight drop are predictors of death from sulfur mustard exposure and may have translational potential as non-invasive
biomarkers.
 Skin exposure to sulfur mustard leads dose-dependent deleterious effects in the skin as well systemic toxicity including precipitous drop in body weight,
peripheral blood cytopenia, and decreased bone marrow cellularity.
 Vitamin D is the ﬁrst drug demonstrated to confer moderate protection from sulfur mustard-induced lethality and may have utility as a chemical
countermeasure given its safety proﬁle and current use in clinical practice.
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A B S T R A C T
The use of sulfur mustard (SM) as a chemical weapon for warfare has once again assumed center stage,
endangering civilian and the military safety. SM causes rapid local skin vesication and late-onset systemic
toxicity. Most studies on SM rely on obtaining tissue and blood for characterizing burn pathogenesis and
assessment of systemic pathology, respectively. However the present study focuses on developing a non-
invasive method to predict mortality from high dose skin SM exposure. We demonstrate that exposure to
SM leads to a dose dependent increase in wound area size on the dorsal surface of mice that is
accompanied by a progressive loss in body weight loss, blood cytopenia, bone marrow destruction, and
death. Thus our model utilizes local skin destruction and systemic outcome measures as variables to
predict mortality in a novel skin-based model of tissue injury. Based on our recent work using vitamin D
(25(OH)D) as an intervention to treat toxicity from SM-related compounds, we explored the use of 25
(OH)D in mitigating the toxic effects of SM. Here we show that 25(OH)D offers protection against SM and
is the ﬁrst known demonstration of an intervention that prevents SM-induced mortality. Furthermore, 25
(OH)D represents a safe, novel, and readily translatable potential countermeasure following mass toxic
exposure.
ã 2016 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY
license (http://creativecommons.org/licenses/by/4.0/).
Contents lists available at ScienceDirect
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Sulfur mustard (SM) has been used as a chemical weapon in
World War I and during inter-war periods causing life-threatening
injury for which there is currently no speciﬁc treatment. Indeed
the recent past has once again witnessed the horrors of SM* Corresponding author at: BRB Rm529, 2109 Adelbert Road, Cleveland, OH
44106, United States.
E-mail address: Kurt.Lu@case.edu (K. Q. Lu).
http://dx.doi.org/10.1016/j.toxlet.2016.02.013
0378-4274/ã 2016 The Authors. Published by Elsevier Ireland Ltd. This is an open accere-emerging as an arsenal for combat so the pressure is on, more
than ever, to intensify the search for effective intervention. In this
study we use SM as the inducer of chemical injury which possesses
a range of toxicities with exposure to varying intensities. Low dose
cutaneous exposure to SM results in erythema and burning (Borak
and Sidell, 1992; Requena et al., 1988), while higher doses are
associated with full thickness necrosis, skin vesication and
disruption of the dermal-epidermal junction (Sidell et al., 1997).
Massive exposures lead to systemic toxicity and death. Despite
these studies, the threshold of dose exposure that would generate ass article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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established. We have recently shown in a nitrogen mustard
(NM) induced skin wound model that 5 ng 25(OH)D, when
administered intraperitoneally at 1 h following exposure, acceler-
ated wound healing and rescued mice from mortality in an
inducible nitric oxide synthese (iNOS)-dependent manner. A single
dose of 25(OH)D accelerated skin wound healing, recovery from
NM-mediated bone marrow disruption and pancytopenia and
prevented a precipitous drop in body weight and subsequent death
(Au et al., 2015). Since NM share similar vesicant and toxicity
proﬁles with SM, various studies have utilized NM to serve as the
less aggressive surrogate toxicant of SM (Goswami et al., 2015;
Malaviya et al., 2012). Our model demonstrates that early effects of
SM exposure causes extensive erosion of the epidermal layer of
skin, inﬂammation and full thickness necrosis while late effects are
associated with massive disruption of hematopoiesis leading to
death as the end point. To date there have no effective counter-
measures that offer protection from SM mediated death. Given our
LD70 dose of SM by day 6 following exposure, we explored the use
of one dose of 25(OH)D and demonstrate signiﬁcant protection
from lethality. Most studies in experimental animal models
evaluate tissue damage from SM exposure from invasive skin
biopsies, blood and bone marrow aspirates however the present
model focuses on developing a non-invasive method to predict
mortality from high dose cutaneous SM exposure.Fig. 1. SM-induced skin injury is exacerbated by inﬁltration of inﬂammatory macrophag
48 h post SM exposure, B) SM-induced lesion area measured over a 5 day period, n = 4 p
measured in mice treated with selective doses of 50, 55 and 60 mg/kg SM, n = 10, *p = 0.02
on day 4. Exposure to 50 mg/kg rendered a stable LD70 model, therefore subsequent expe
from excised biopsies obtained after 48 h post SM exposure. Arrows indicate cellular in
exposed mouse skin colocalizing F4/80+ macrophages and iNOS+ cells. Scale bar = 100u2. Materials and methods
2.1. Mice
Pathogen-free, six week old female C57/BL6J mice were
purchased from Jackson Laboratories (Bar Harbor, Maine). Animals
were quarantined according to Battelle standard operating
procedure (SOP). All animals receive standard laboratory diet.
Anesthetic calculations were based on weights obtained during
quarantine. An anesthesia cocktail of a 10 ml/kg mixture of
ketamine hydrochloride (Fort Dodge,100 mg/ml) and xylazine
hydrochloride (Lloyd, 20 mg/ml) was administered by intraperito-
neal (IP) injection. Hair on the dorsal back of mice was removed by
clippers and depilation as previously described (Au et al. JID. 2015).
Mice were allowed to rest for 72 h before initiating SM exposure
experiments.
2.2. Sulfur mustard
SM was supplied by U.S. Army Edgewood Chemical Biological
Center (Aberdeen Proving Ground, MD). The SM purity value was
>96 percent as determined by gas chromatography. As part of the
dose ﬁnding study, SM dissolved in DMSO [Hyclone; Logan, UT], was
applied at 8 different concentrations (4.8, 8.2, 14, 23.6, 40, 68, 89 and
116 mg/kg) over an area approximately 8 mm in diameter on thees. Presented in a dose dependent manner are A) representative images of skin wounds
er group. C) The threshold dose of SM was reﬁned to ensure an LD90 model. Lesion area
5 comparing 50 mg/kg:60 mg/kg on day 3, **p = 0.05 comparing 50 mg/kg:60 mg/kg
riments utilized 50 mg/kg SM as dose of exposure. These included D) H&E skin sections
ﬁltration. E) Confocal images of epidermis/dermis (upper panel) of control vs. SM-
M.
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doses of 50, 55 and 60 mg/kg were applied on mice. Control mice were
applied DMSO only.
2.3. Vitamin D
25(OH)D (Sigma-Aldrich) was reconstituted in ethanol and
further diluted in mineral oil Sigma-Aldrich Chemical Company,
Inc. (St. Louis, MO), for use. 5 ng of 25(OH)D was injected
intraperitoneally using a 27 gauge needle (Beckton Dickinson
Bioscience; Franklin Lakes, NJ) 1 h following SM exposure.
Untreated mice receiving SM only were injected with mineral oil.
2.4. Wound area size and total body weight measurements
Wounds were measured with a digital caliper daily for 5 days
following SM exposure. All mice in the study were weighed daily
till day 5 or till drop in body weight met euthanasia criteria.Fig. 2. High dose SM exposure results in signiﬁcant loss of body weight and increased mo
68 mg/kg and ***p = 0.0002 for 116 mg/kg, compared to control, n = 4 per group, B) Dose dep
n = 10 for each group, p = 0.01 by Log Rank test. SM mediated systemic tissue destruction
SM dose 5 days post exposure, D) cell viability, n = 4 for controls, n = 8 for SM exposed ani
graphical representation of cell number per HPF from blood smears,*p = 0.05, **p = 0.002.5. Blood smear
A drop of blood was collected from SM exposed and control mice
and transferred onto a glass slide by tail snip, smeared using a
microscope slide (Fisher Scientiﬁc), ﬁxed in 100% methanol (Fisher
Scientiﬁc), and stained with Wright-Giemsa to observe cell types
and enumerate red blood cells per high power ﬁeld (HPF).
2.6. Complete blood count (CBC)
Blood was collected from mice undergoing sacriﬁce on day 5 and
analyzed for complete blood count using a hematology analyzer at
Battelle R&D facility (Columbus, OH)
2.7. H&E staining
Sternums and skin of euthanized mice were removed and ﬁxed
overnight in 10% formalin diluted in PBS (Fisher Scientiﬁc).
Sternums were embedded in parafﬁn, sectioned (8 mm thickness),rtality. A) Dose dependent loss in body weight *p = 0.039 for 89 mg/kg, **p = 0.009 for
endent survival curve of mice treated with SM ranging from 4.8 mg/kg to 116 mg/kg,
 observed through C) loss of cellularity in H&E sections of bone marrow at 50 mg/kg
mals, E) altered cellularity in peripheral blood of mice 5 days post SM exposure, F)
5, ***p  0.0006, compared to control, n = 3 per group. Scale bar 100 mm.
Table 1
CBC analyses of SM exposed mouse on day 5 post exposure.
CBC analysis Control SM(50.0 mg/kg)
n = 3 n = 4
WBC(103/ml) 3.21  0.66 0.73  0.16
HT(%) 27.60  9.31 13.65  3.87
Lymph (103/ml) 2.31  0.54 0.42  0.11
Mono (103/ml) 0.05  0.02 0.01  0.01
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induced cellular depletion.
2.8. Immunoﬂuorescence staining
Freshly harvested skin and sternum designated for immunoﬂuo-
rescence studies were OCT-embedded and analyzed as previously
described (Au et al. 2015). Primary antibodies were diluted in 10%
goat serum: anti-mouse F4/80 antigen Alexa-488; rat IgG2a
isotype—Alexa 488 (eBioscience, SanDiego, CA, 1:100); rabbit-
anti-mouse iNOS (Upstate Temecula, CA); isotype rabbit IgG (R&D
Systems Minneapolis, MN). Secondary antibodies: goat anti-rabbit
Alexa Fluor 647 conjugated (1:2000 in 1X PBS) (Life Technologies
Grand Island, NY). Labeled sections were imaged using a Ultra-
VIEW VoX spinning disk confocal microscope (Leica DMI6000B).
2.9. Bone marrow cell isolation
Tibiae and femurs of mice were isolated to harvest bone marrow
cells as described before (Horak et al., 1983). Viable cells were
enumerated in SM-exposed mice and compared with controls.
2.10. Statistical analysis
A 2 sided unpaired t-test was used to compare mean values. The
Kaplan-Meier method was used to plot the survival distributions of
all groups (SM and SM + 25(OH)D) which were then compared
using the log-rank test. A Cox regression analysis was used to
assess mortality hazard as a function of lesion size and body weight
loss. Data are presented as mean  s.e.m, and p values 0.05 were
considered signiﬁcant.
3. Results
3.1. SM-induced skin injury is exacerbated by inﬁltration of
inﬂammatory macrophages
We developed a SM skin exposure mouse model in which
dorsally shaved mice received 8 different concentrations of SM
topically applied (in DMSO) onto a 50 mm2 circular area (8 mm
diameter). The challenge dose range (4.8–116 mg/kg SM) was
selected in order to reduce conﬁdence limits around LD90 and
obtain a statistically signiﬁcant probit slope. Skin lesions were
evident in all SM challenged groups with representative images
shown in Fig. 1A.
Wounds progressed with visible erythema associated with
hemorrhagic crust that remained enlarged resulting in full
thickness necrosis and a dose dependent increase in wound area
size from 4 to 70 mm2 (Fig. 1B). We selected 50 mg/kg SM as the
working dose as this produced statistically signiﬁcant wound area
changes at days 3 and 4 (n = 10, p = 0.05, p = 0.025), respectively
(Fig. 1C). In this study 48 h was chosen for detection of maximum
skin pathology based on our recently published results from a
mouse model of cutaneous nitrogen mustard exposure (Au et al.,
2015). Histological evaluation of skin lesion 48 h following SM
exposure at 50 mg/kg reveal death and erosion of the epidermal
layer, disruption of hair follicles and inﬂammatory inﬁltration from
SM mediated excessive tissue damage (Fig. 1D). Investigation of
inﬁltrating cells in SM-inﬂamed skin sections by confocal
microscopy showed a predominance of iNOS producing macro-
phages populating the dermis 48 h after exposure, suggesting an
association between early tissue destruction and a predominance of
iNOS macrophages inﬁltrating the wound bed (Fig. 1E). This is
supported by data from our recent publication demonstrating that
cutaneous exposure to nitrogen mustard resulted in skin lesionthat were exacerbated by activated macrophages in an iNOS-
dependent manner (Au et al., 2015).
3.2. Systemic weight loss and bone marrow disruption following high
dose SM exposure
Mustard gas exposures have been associated with mortality
consequently we investigated the systemic impact of SM exposure
on skin. A daily progressive body weight loss of 4–6% and wasting
was recorded in SM-exposed mice in a dose-dependent manner
(Fig. 2A). Doses of 68 mg/kg and above corresponded with 100%
mortality by day 5 (Kaplan Mieier curve, Fig. 2B), corroborating
previous studies that demonstrated morbidity and body weight
loss from high dose skin exposures to SM in mice (Goswami et al.,
2015).
To establish a reproducible LD90 dose that would exert a dual
effect of dermal destruction and systemic tissue destruction, mice
were exposed to 4 doses of SM between 40 mg/kg (modest weight
loss with no mortality) and 68 mg/kg (100% mortality by day 5)
(data not shown). Interestingly, we observe no mortality with
exposure to SM at doses  40 mg/kg, although doses  45 mg/kg
appeared to be a critical threshold for death resulting in a stable
LD70 at 50 mg/kg (Fig. 2B, pink line). Hematopoietic suppression in
mustard gas victims has been the principal cause of SM associated
mortality (Meisenberg et al., 1993) and our model recapitulates the
phenotype such that cutaneous exposure to SM at 50 mg/kg
induces acute loss of bone marrow cellularity as observed from
H&E staining of sternum sections of SM mice 5 days post exposure
(Fig. 2C). Parallel to sternal marrow disruption in SM mice, bone
marrow cells isolated from the femur of SM exposed mice also
exhibited acute cell depletion (analyzed by ﬂow cytometry) (Fig. 2D).
This observation was marked by cytopenia (Fig. 2E) with a 60% drop in
peripheral red blood cells (261 cells per HPF in SM-exposed mice vs
640 cells per HPF in control mice, p < 0.005) (Fig. 2F). Finally, a 4-fold
loss of white blood cells (WBC) and a 2-fold decrease of hematocrit
(HCT) was recorded from CBC analysis supporting the evidence that
skin exposure to SM precipitates in extensive and often fatal
systemic pathology (Table 1).
3.3. Lesion area and weight loss can independently predict SM-
induced mortality: protective role of 25(OH)D
Based on progressive exacerbation of skin wound associated
with increased wound area, the latter was considered an
independent and statistically signiﬁcant parameter to predict
mortality following SM exposure (Fig. 3A). Using lesion size and
maximum body weight loss as independent and statistically
signiﬁcant quantiﬁable outcomes, we developed a model to predict
SM-induced lethality. The Cox regression analysis utilizes hazard
ratios (HR) as a function of the variables (lesion size and body weight).
HR<1 signiﬁes inverse relationship between the predictor and its
outcome whereas an HR >1 indicates a direct relationship. The HR for
the weight variable (a surrogate for systemic pathology) was 0.391,
indicating an expected inverse relationship between the weight
Fig. 3. Lesion area as an independent predictor of mortality in presence and absence of a single dose of 25(OH)D. A) Cox regression analysis used lesion area at day 5
post exposure as an independent variable to develop a model to predict mortality of SM challenged mice at 50 mg/kg dose, n = 60. B) Intervention with 25(OH)D at 5 ng/ml
1 h post SM-exposure protects 40% of the mice from SM mediated death as assessed by a Log Rank test (p = 0.01), n = 26 for SM exposed animals, n = 32 for SM  25(OH)D
treated animals.gr3
Table 2
Cox Regression Analysis. Body weight and lesion area are independent and statistically signiﬁcant predictors of mortality.
Parameter p-value Hazard Ratio 95% Hazard Ratio Conﬁdence Limits
Weight at day 5 <0.0001 0.391 0.255 0.600
Lesion area at day 5 0.0489 1.017 1.000 1.035
L.M. Das et al. / Toxicology Letters 248 (2016) 9–15 13and mortality. The HR for the lesion size (marker of local tissue
destruction) was 1.017, indicative of a directly proportional
relationship between the size of the lesion and mortality (Table 2).The data presented deﬁnes 50 mg/kg SM in DMSO as the
minimum dose that elicits a sufﬁcient local (skin lesion) and
systemic (blood & bone marrow alteration) response to generate an
14 L.M. Das et al. / Toxicology Letters 248 (2016) 9–15LD70 lethality model. Based on the efﬁcacy of 25(OH)D in rescuing
mice from NM-induced pathology (Au et al., 2015), 25(OH)D was
used as potential countermeasure to mitigate the adverse effects of
SM induced damage to skin and other organs. A single dose of 25
(OH)D at 5 ng/ml administered intraperitoneally (IP) demonstrated
a moderate 40% protection from lethality that
was statistically signiﬁcant by (n = 60, Log Rank test, p = 0.01)
(Fig. 3B). These data suggests that SM exposure imparts a skin
pathology and weight loss that can be utilized in developing an
LD70 model in mice that is attenuated by 25(OH)D.
4. Discussion
Our ﬁndings suggest that skin exposure to SM precipitates in an
acute phenotype in mice characterized by skin ulceration, body
weight loss and death, all of which progress in a dose dependent
manner. We demonstrate that the early effects following challenge
with SM include skin destruction that penetrates deep into the
dermis through massive inﬁltration of activated macrophages
producing elevated levels of iNOS. In most experimental animal
models studied cutaneous wounds from SM burn progress with an
inﬂammatory burst which critically inﬂuences the kinetics of
wound healing (Mouret et al., 2014; Woessner et al., 1990). While
models demonstrating vesicant-induced injury in lungs have been
associated with inﬂammation induced iNOS production (Sunil
et al., 2012), other studies suggest that iNOS production is inhibited
by SM mediated skin injury (Ishida et al., 2008). Our NM skin
exposure model established that iNOS plays a critical role in
vesicant mediated skin tissue destruction (Au et al., 2015). Given
the observation of skin inﬁltration with F4/80 + iNOS+ macro-
phages following SM exposure, we speculate that the immune
system may play a role in exacerbating vesicant mediated injury.
Erosion of the epidermal layer and inﬂammatory inﬁltration from
SM mediated tissue damage are some of the classic features
observed in studies on SKH-1 male mice exposed to SM vapor
injury (Clery-Barraud et al., 2013). Although SM-mediated lung
and ocular injuries have been recapitulated in several experimen-
tal animal models, percutaneous exposure to SM remains the
principal and most rapid route of toxic penetration to inﬂict
destruction to internal organs and blood (Langenberg et al., 1998).
In accordance with other models of skin exposure to SM
(Langenberg et al., 1998), our studies show that depletion of bone
marrow cells correlate with cytopenia observed at day 5 post
exposure. We establish from blood smear analyses that SM
exposure depletes peripheral red blood cells by 60% (261 cells/
HPF) compared to control mice (640 cells/HPF) (p < 0.005). The
combination of the appearance of lesions, weight loss, cytopenia,
bone marrow depression, and death were the parameters used for
the acceptance of this model for use in the assessment of
therapeutics against topical SM exposure. This study deﬁned a
dose of 50 mg/kg in DMSO to be an acceptable level for sufﬁcient
lesion formation and molecular insult to the bone marrow. Thus in
this study we have established an optimal SM skin exposure model
for tissue damage and death.
Vitamin D is widely available and has been shown to be
beneﬁcial in a NM skin vesication model and thus could have a
broad public health impact in the event of chemical weapon
exposure. A prospective study on patients with leg ulcers are
associated with acute vitamin D deﬁciency that upon treatment
with vitamin D shows a trend towards accelerated healing
(Burkiewicz et al. 2012) suggesting that 25(OH)D may impact
wound healing. Given the potential translational signiﬁcance of
vitamin D3 in suppressing skin and blood levels of iNOS and
macrophages following exposure to nitrogen mustard, we developed a
model to test whether 25(OH)D administered to SM-exposed mice
may offer some protection against the deleterious effects of SM. Thecurrent work using one dose of 25(OH)D shows moderate protection
from lethality. Ongoing work will determine if different dosing
regimens can attenuate inﬂammation induced tissue destruction. One
of the factors supporting enhanced inﬂammation in SM-exposed skin
of Iranian war veterans is reportedly due to reduced expression levels
of anti-inﬂammatory cytokines like TGF-b (Valizadeh et al., 2015)
during the wound healing process. Our data contributes to that
scenario by demonstrating that SM induced inﬂammation is
associated with a surge of inﬂammatory inﬁltrates that may offset
the action of the anti-inﬂammatory factors. Although medical
advances have made attempts to counter the adverse effects of
percutaneous exposure to mustard gas, treatment options to
individuals are still dependent on late-appearing symptoms. To avoid
situations of triaging patients based on severity of exposure, oral
intake of a “safe” study drug like vitamin D by all victims would
attenuate the ﬁrst surge of inﬂammation and substantially reduce
ampliﬁcation of that response. In military zones with limited medical
amenities, a rapid screening of patients that present with progres-
sively increasing lesion sizes would be subject to further treatment
compared to those with improved wound sizes. Vitamin D taken early
on would potentially facilitate in containing the early immune
responses and would be a key step in rescuing victims from the
damaging effects of SM exposure.
In conclusion this study establishes that SM exposure to skin
sustains skin vesication including formation of inﬂammatory foci
at the site of exposure. Local skin destruction is accompanied by
progressive weight loss that contributes to mortality. Our results
provide the ﬁrst evidence that early intervention with 25(OH)D offers
protection from SM induced injury. Utilizing progressive increase in
wound area and loss in body weight as the two key variables, our
model presents a stable platform for advancing research to test the
efﬁcacy of potential countermeasures like 25(OH)D that would offer
treatment options to exposed victims.
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